226 related articles for article (PubMed ID: 28751088)
1. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use.
Cheng HC; Yang EH; Wu CT; Wang WL; Chen PJ; Lin MY; Sheu BS
J Formos Med Assoc; 2018 Apr; 117(4):316-325. PubMed ID: 28751088
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
3. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6.
Yang EH; Wu CT; Kuo HY; Chen WY; Sheu BS; Cheng HC
Surg Endosc; 2020 Apr; 34(4):1592-1601. PubMed ID: 31222633
[TBL] [Abstract][Full Text] [Related]
4. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.
Lanas A; Polo-Tomas M; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Calvet X; Feu F; Perez-Aisa A; Sung JJ
Scand J Gastroenterol; 2013 Mar; 48(3):285-94. PubMed ID: 23298283
[TBL] [Abstract][Full Text] [Related]
5. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use: Methodological issues.
Safiri S; Ayubi E
J Formos Med Assoc; 2018 Mar; 117(3):250-251. PubMed ID: 29175145
[No Abstract] [Full Text] [Related]
6. Reply to "Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use: Methodological issues".
Cheng HC; Sheu BS
J Formos Med Assoc; 2018 Mar; 117(3):252-253. PubMed ID: 29183692
[No Abstract] [Full Text] [Related]
7. Treatment and prognosis in peptic ulcer bleeding.
Laursen SB
Dan Med J; 2014 Jan; 61(1):B4797. PubMed ID: 24547604
[TBL] [Abstract][Full Text] [Related]
8. Intravenous albumin shortens the duration of hospitalization for patients with hypoalbuminemia and bleeding peptic ulcers: a pilot study.
Cheng HC; Chang WL; Chen WY; Tsai YC; Yeh YC; Sheu BS
Dig Dis Sci; 2013 Nov; 58(11):3232-41. PubMed ID: 23934414
[TBL] [Abstract][Full Text] [Related]
9. Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study.
Cheng HC; Wu CT; Chang WL; Cheng WC; Chen WY; Sheu BS
Gut; 2014 Dec; 63(12):1864-72. PubMed ID: 24658598
[TBL] [Abstract][Full Text] [Related]
10. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
[TBL] [Abstract][Full Text] [Related]
11. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan.
Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N
Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780
[TBL] [Abstract][Full Text] [Related]
12. Peptic ulcer bleeding patients with Rockall scores ≥6 are at risk of long-term ulcer rebleeding: A 3.5-year prospective longitudinal study.
Yang EH; Cheng HC; Wu CT; Chen WY; Lin MY; Sheu BS
J Gastroenterol Hepatol; 2018 Jan; 33(1):156-163. PubMed ID: 28497645
[TBL] [Abstract][Full Text] [Related]
13. Bleeding peptic ulcers: the current management.
Chiu PW
Dig Endosc; 2010 Jul; 22 Suppl 1():S19-21. PubMed ID: 20590764
[TBL] [Abstract][Full Text] [Related]
14. [Comparison between Endoscopic Therapy and Medical Therapy in Peptic Ulcer Patients with Adherent Clot: A Multicenter Prospective Observational Cohort Study].
Kim SH; Jung JT; Kwon JG; Kim EY; Lee DW; Jeon SW; Park KS; Lee SH; Park JB; Ha CY; Park YS;
Korean J Gastroenterol; 2015 Aug; 66(2):98-105. PubMed ID: 26289243
[TBL] [Abstract][Full Text] [Related]
15. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.
Tsai JJ; Hsu YC; Perng CL; Lin HJ
Br J Clin Pharmacol; 2009 Mar; 67(3):326-32. PubMed ID: 19523014
[TBL] [Abstract][Full Text] [Related]
16. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse.
Camus M; Jensen DM; Kovacs TO; Jensen ME; Markovic D; Gornbein J
Aliment Pharmacol Ther; 2016 May; 43(10):1080-9. PubMed ID: 27000531
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
[TBL] [Abstract][Full Text] [Related]
18. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
[TBL] [Abstract][Full Text] [Related]
19. High- versus low-dose proton pump inhibitors post endoscopic hemostasis in hemodialysis cases with peptic ulcer bleeding.
Salman AA; Salman MA; Sarhan MD; Shaaban HE; Yousef M; Ibrahim A; Tourky M; Youssef A; Sherbiny ME
Acta Gastroenterol Belg; 2021; 84(1):3-8. PubMed ID: 33639687
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
